Reference Amounts Customarily Consumed: List of Products for Each Product Category; Guidance for Industry; Availability, 9000-9001 [2018-04283]
Download as PDF
9000
Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices
II. Electronic Access
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/Drugs/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm, https://
www.fda.gov/BiologicsBloodVaccines/
GuidanceComplianceRegulatory
Information/Guidances/default.htm, or
https://www.regulations.gov.
Dated: February 23, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–04181 Filed 3–1–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–D–4098]
Reference Amounts Customarily
Consumed: List of Products for Each
Product Category; Guidance for
Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a
guidance for industry entitled
‘‘Reference Amounts Customarily
Consumed: List of Products for Each
Product Category.’’ The guidance
provides examples of products that
belong to product categories included in
the tables of Reference Amounts
Customarily Consumed (RACCs) per
Eating Occasion established in our
regulations.
DATES: The announcement of the
guidance is published in the Federal
Register on March 2, 2018.
ADDRESSES: You may submit either
electronic or written comments on FDA
guidances at any time as follows:
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
VerDate Sep<11>2014
18:10 Mar 01, 2018
Jkt 244001
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2016–D–4098 for ‘‘Reference Amounts
Customarily Consumed: List of Products
for Each Product Category.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Office of
Nutrition and Food Labeling, Center for
Food Safety and Applied Nutrition,
Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740.
Send two self-addressed adhesive labels
to assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Jillonne Kevala, Center for Food Safety
and Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–1450.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a guidance for industry entitled
‘‘Reference Amounts Customarily
Consumed: List of Products for Each
Product Category.’’ We are issuing this
guidance consistent with our good
guidance practices regulation (21 CFR
10.115). The guidance represents the
current thinking of FDA on this topic.
It does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations. This guidance is not subject
to Executive Order 12866.
This guidance is intended to help
industry comply with the statutory
requirement, under section
403(q)(1)(A)(i) of the Federal Food,
Drug, and Cosmetic Act (FD&C Act) (21
U.S.C. 343(q)(1)(A)(i)), that food that is
intended for human consumption and
offered for sale bear nutrition
information that provides a serving size
E:\FR\FM\02MRN1.SGM
02MRN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices
that reflects the amount of food
customarily consumed and is expressed
in a common household measure that is
appropriate to the food. To comply with
this requirement, manufacturers must
determine and label their food products
with the appropriate label serving size
based on the amount of the product
customarily consumed.
In the Federal Register of May 27,
2016, we issued a final rule entitled
‘‘Food Labeling: Serving Sizes of Foods
That Can Reasonably Be Consumed at
One Eating Occasion; Dual-Column
Labeling; Updating, Modifying, and
Establishing Certain Reference Amounts
Customarily Consumed; Serving Size for
Breath Mints; and Technical
Amendments’’ (81 FR 34000). The final
rule amends our regulations in
§ 101.12(b) (21 CFR 101.12(b)) to update
or modify certain pre-existing RACCs,
and to establish RACCs for new product
categories.
In the Federal Register of January 5,
2017 (82 FR 1344), we announced the
availability of a draft guidance for
industry entitled ‘‘Reference Amounts
Customarily Consumed: List of Products
for Each Product Category; Draft
Guidance for Industry’’ and gave
interested parties an opportunity to
submit comments by March 6, 2017, for
us to consider before beginning work on
the final version of the guidance. We
received several comments on the draft
guidance and have modified the
content, where appropriate, for this final
guidance. Changes to the guidance
include the addition of flavored nut
butter spreads (e.g., cocoa, cookie, and
coffee flavored) as an example in the
‘‘Nut and seed butters, pastes, or
creams’’ product category. In the
Federal Register of November 2, 2016,
we published a Request for Information
and Comments requesting information
and comments on the appropriate
product category and RACC for flavored
nut butter spreads (e.g., cocoa, cookie,
and coffee flavored) (81 FR 76323).
Based upon the information and
comments received, and our own
assessment, we have determined that
flavored nut butter spreads (e.g., cocoa,
cookie, and coffee flavored) are
comparable to nut butters and belong in
the ‘‘Nut and seed butters, pastes, or
creams’’ product category with a RACC
of two tablespoons. In addition to this
and other clarifying substantive changes
that we made to the guidance, we made
editorial changes to improve clarity and
to help ensure consistency with
§ 101.12(b). The guidance announced in
this notice finalizes the draft guidance
dated January 2017.
VerDate Sep<11>2014
18:10 Mar 01, 2018
Jkt 244001
II. Electronic Access
Persons with access to the internet
may obtain the guidance at either
https://www.fda.gov/FoodGuidances or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
Dated: February 27, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–04283 Filed 3–1–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–1112]
United States Food and Drug
Administration and Health Canada
Joint Regional Consultation on the
International Council for
Harmonisation of Technical
Requirements for Pharmaceuticals for
Human Use; Public Meeting; Request
for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA or Agency) is
announcing a regional public meeting
entitled ‘‘U.S. Food and Drug
Administration and Health Canada Joint
Regional Consultation on the
International Council for Harmonisation
of Technical Requirements for
Pharmaceuticals for Human Use (ICH).’’
The purpose of the public meeting is to
provide information and solicit public
input on the current activities of the
ICH, as well as the upcoming ICH
Assembly Meeting and the Expert
Working Group Meetings in Kobe,
Japan, scheduled for June 4 through 7,
2018. The topics to be addressed at the
public meeting are the current ICH
guideline topics under development
that will be discussed at the
forthcoming ICH Assembly Meeting in
Kobe.
SUMMARY:
The public meeting will be held
on Friday, April 6, 2018, from 10 a.m.
to 1 p.m. Submit either electronic or
written comments on this public
meeting by April 30, 2018. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public meeting will be
held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
DATES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
9001
Conference Center, Rm. 1503 (Great
Room), Silver Spring, MD 20993–0002.
The meeting will also be broadcast on
the web, allowing participants to join in
person OR via the web. For those who
will attend in person, the entrance for
the public meeting participants (nonFDA employees) is through Building 1
where routine security check
procedures will be performed. For
parking and security information, please
refer to https://www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm. For those who register
to attend the public meeting remotely
via the webcast, a link to access the
webcast will be emailed 1 week in
advance of the meeting.
You may submit comments as
follows. Please note that late, untimely,
filed comments will not be considered.
Electronic comments must be submitted
on or before April 30, 2018. The https://
www.regulations.gov electronic filing
system will accept comments until
midnight Eastern Time at the end of
April 30, 2018. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are postmarked or the
delivery service acceptance receipt is on
or before that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed in the sections below
(see ‘‘Written/Paper Submissions’’ and
‘‘Instructions’’).
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 83, Number 42 (Friday, March 2, 2018)]
[Notices]
[Pages 9000-9001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04283]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-D-4098]
Reference Amounts Customarily Consumed: List of Products for Each
Product Category; Guidance for Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
availability of a guidance for industry entitled ``Reference Amounts
Customarily Consumed: List of Products for Each Product Category.'' The
guidance provides examples of products that belong to product
categories included in the tables of Reference Amounts Customarily
Consumed (RACCs) per Eating Occasion established in our regulations.
DATES: The announcement of the guidance is published in the Federal
Register on March 2, 2018.
ADDRESSES: You may submit either electronic or written comments on FDA
guidances at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2016-D-4098 for ``Reference Amounts Customarily Consumed: List of
Products for Each Product Category.'' Received comments will be placed
in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the guidance to the
Office of Nutrition and Food Labeling, Center for Food Safety and
Applied Nutrition, Food and Drug Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two self-addressed adhesive labels to
assist that office in processing your request. See the SUPPLEMENTARY
INFORMATION section for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT: Jillonne Kevala, Center for Food
Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240-402-1450.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a guidance for industry
entitled ``Reference Amounts Customarily Consumed: List of Products for
Each Product Category.'' We are issuing this guidance consistent with
our good guidance practices regulation (21 CFR 10.115). The guidance
represents the current thinking of FDA on this topic. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations. This guidance
is not subject to Executive Order 12866.
This guidance is intended to help industry comply with the
statutory requirement, under section 403(q)(1)(A)(i) of the Federal
Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 343(q)(1)(A)(i)),
that food that is intended for human consumption and offered for sale
bear nutrition information that provides a serving size
[[Page 9001]]
that reflects the amount of food customarily consumed and is expressed
in a common household measure that is appropriate to the food. To
comply with this requirement, manufacturers must determine and label
their food products with the appropriate label serving size based on
the amount of the product customarily consumed.
In the Federal Register of May 27, 2016, we issued a final rule
entitled ``Food Labeling: Serving Sizes of Foods That Can Reasonably Be
Consumed at One Eating Occasion; Dual-Column Labeling; Updating,
Modifying, and Establishing Certain Reference Amounts Customarily
Consumed; Serving Size for Breath Mints; and Technical Amendments'' (81
FR 34000). The final rule amends our regulations in Sec. 101.12(b) (21
CFR 101.12(b)) to update or modify certain pre-existing RACCs, and to
establish RACCs for new product categories.
In the Federal Register of January 5, 2017 (82 FR 1344), we
announced the availability of a draft guidance for industry entitled
``Reference Amounts Customarily Consumed: List of Products for Each
Product Category; Draft Guidance for Industry'' and gave interested
parties an opportunity to submit comments by March 6, 2017, for us to
consider before beginning work on the final version of the guidance. We
received several comments on the draft guidance and have modified the
content, where appropriate, for this final guidance. Changes to the
guidance include the addition of flavored nut butter spreads (e.g.,
cocoa, cookie, and coffee flavored) as an example in the ``Nut and seed
butters, pastes, or creams'' product category. In the Federal Register
of November 2, 2016, we published a Request for Information and
Comments requesting information and comments on the appropriate product
category and RACC for flavored nut butter spreads (e.g., cocoa, cookie,
and coffee flavored) (81 FR 76323). Based upon the information and
comments received, and our own assessment, we have determined that
flavored nut butter spreads (e.g., cocoa, cookie, and coffee flavored)
are comparable to nut butters and belong in the ``Nut and seed butters,
pastes, or creams'' product category with a RACC of two tablespoons. In
addition to this and other clarifying substantive changes that we made
to the guidance, we made editorial changes to improve clarity and to
help ensure consistency with Sec. 101.12(b). The guidance announced in
this notice finalizes the draft guidance dated January 2017.
II. Electronic Access
Persons with access to the internet may obtain the guidance at
either https://www.fda.gov/FoodGuidances or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
Dated: February 27, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-04283 Filed 3-1-18; 8:45 am]
BILLING CODE 4164-01-P